Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia
Prasca S, Carmona R, Ji L, Ko R, Bhojwani D, Rawlins Y, Mittelman S, Young G, Orgel E. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia. Thrombosis Research 2018, 165: 44-50. PMID: 29567586, PMCID: PMC7522001, DOI: 10.1016/j.thromres.2018.02.150.Peer-Reviewed Original ResearchConceptsDual-energy X-ray absorptiometryAcute lymphoblastic leukemiaSymptomatic venous thromboembolismVenous thromboembolismLymphoblastic leukemiaDevelopment of venous thromboembolismPediatric acute lymphoblastic leukemiaAcute lymphoblastic leukemia therapyRetrospective cohort of childrenX-ray absorptiometryLong-term morbiditySubgroup of patientsVenous thromboembolism riskRisk-stratified approachMeasures of body fatCohort of childrenALL cohortStudy-definedRetrospective cohortVTE riskContemporary therapyIncreased riskBody compositionBody fatObesity